IL88735A - N-benzimidazolyl 4-chloro-3- sulfamoylbenzoic acid hydrazides, a process for the preparation thereof and pharmaceutical compositions containing them - Google Patents

N-benzimidazolyl 4-chloro-3- sulfamoylbenzoic acid hydrazides, a process for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL88735A
IL88735A IL88735A IL8873588A IL88735A IL 88735 A IL88735 A IL 88735A IL 88735 A IL88735 A IL 88735A IL 8873588 A IL8873588 A IL 8873588A IL 88735 A IL88735 A IL 88735A
Authority
IL
Israel
Prior art keywords
group
carbon atoms
benzimidazolyl
chloro
preparation
Prior art date
Application number
IL88735A
Other languages
English (en)
Other versions
IL88735A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL88735A0 publication Critical patent/IL88735A0/xx
Publication of IL88735A publication Critical patent/IL88735A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/22—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL88735A 1987-12-30 1988-12-20 N-benzimidazolyl 4-chloro-3- sulfamoylbenzoic acid hydrazides, a process for the preparation thereof and pharmaceutical compositions containing them IL88735A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876131A HU207051B (en) 1987-12-30 1987-12-30 Process for producing 4-chloro-3-sulfamoylbenzoic acid hydrazides and pharmaceutical compositions comprising such compounds

Publications (2)

Publication Number Publication Date
IL88735A0 IL88735A0 (en) 1989-07-31
IL88735A true IL88735A (en) 1992-12-01

Family

ID=10971250

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88735A IL88735A (en) 1987-12-30 1988-12-20 N-benzimidazolyl 4-chloro-3- sulfamoylbenzoic acid hydrazides, a process for the preparation thereof and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (1) US4916149A (fi)
EP (1) EP0324988B1 (fi)
JP (1) JPH01213269A (fi)
CN (1) CN1037336A (fi)
AT (1) ATE75467T1 (fi)
AU (1) AU609682B2 (fi)
CA (1) CA1332739C (fi)
CS (1) CS277585B6 (fi)
DD (1) DD283383A5 (fi)
DE (1) DE3870601D1 (fi)
DK (1) DK727488A (fi)
ES (1) ES2034149T3 (fi)
FI (1) FI886045A (fi)
GR (1) GR3004471T3 (fi)
HU (1) HU207051B (fi)
IE (1) IE63246B1 (fi)
IL (1) IL88735A (fi)
NO (1) NO172285C (fi)
NZ (1) NZ227481A (fi)
PH (1) PH25739A (fi)
PL (2) PL158049B1 (fi)
PT (1) PT89368B (fi)
RU (2) RU1838303C (fi)
SU (1) SU1736339A3 (fi)
UA (1) UA19123A (fi)
YU (1) YU47125B (fi)
ZA (1) ZA889729B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU652644B2 (en) * 1991-04-01 1994-09-01 Duke University Method of inhibiting fibrosis
FR2708608B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
DE10132896A1 (de) * 2001-07-06 2003-01-16 Bayer Cropscience Ag Heterocyclische Amidderivate
DE102005002130A1 (de) * 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1122541B (de) * 1959-12-28 1962-01-25 Hoechst Ag Verfahren zur Herstellung von Sulfamyl-anthranilsaeuren
DE1158927B (de) * 1961-09-15 1963-12-12 Werner Rahms Grubenstempel
DE2144908C2 (de) * 1971-09-08 1982-12-09 Hoechst Ag, 6000 Frankfurt 5-(3- oder 4-Aminobenzolsulfonylamino)-benzimidazolone-(2) und Verfahren zu ihrer Herstellung
BE793718A (fr) * 1972-01-07 1973-07-05 Merck & Co Inc Aminobenzimidazoles
DE2247828A1 (de) * 1972-09-29 1974-04-04 Hoechst Ag Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung
US4420487A (en) * 1978-04-10 1983-12-13 The Purdue Frederick Company Diuretic and antihypertensive benzimidazoles

Also Published As

Publication number Publication date
AU609682B2 (en) 1991-05-02
YU47125B (sh) 1994-12-28
PL157971B1 (pl) 1992-07-31
YU240188A (en) 1990-10-31
DD283383A5 (de) 1990-10-10
CN1037336A (zh) 1989-11-22
IE63246B1 (en) 1995-04-05
ZA889729B (en) 1989-10-25
AU2763188A (en) 1989-07-13
NO885830D0 (no) 1988-12-30
DK727488A (da) 1989-07-01
IE883892L (en) 1989-06-30
PL276889A1 (en) 1990-04-02
ES2034149T3 (es) 1993-04-01
IL88735A0 (en) 1989-07-31
CS910888A3 (en) 1992-09-16
GR3004471T3 (fi) 1993-03-31
NO172285B (no) 1993-03-22
PT89368A (pt) 1989-12-29
JPH01213269A (ja) 1989-08-28
EP0324988A1 (de) 1989-07-26
PL158049B1 (pl) 1992-07-31
PH25739A (en) 1991-10-18
DK727488D0 (da) 1988-12-29
RU1838303C (ru) 1993-08-30
DE3870601D1 (de) 1992-06-04
FI886045A (fi) 1989-07-01
EP0324988B1 (de) 1992-04-29
US4916149A (en) 1990-04-10
HUT56550A (en) 1991-09-30
NO885830L (no) 1989-07-03
CS277585B6 (en) 1993-03-17
ATE75467T1 (de) 1992-05-15
NZ227481A (en) 1990-11-27
SU1736339A3 (ru) 1992-05-23
NO172285C (no) 1993-06-30
RU1830064C (ru) 1993-07-23
HU207051B (en) 1993-03-01
PT89368B (pt) 1993-08-31
UA19123A (uk) 1997-12-25
CA1332739C (en) 1994-10-25

Similar Documents

Publication Publication Date Title
AU6064394A (en) Adhesion receptor antagonists
NZ222398A (en) Sulphone compounds containing peroxycarboxylic acid groups; and bleaching compositions
IL75115A (en) 3-oxadiazolyl-beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
IL113011A (en) R-mandelic acid salt of (2s,3s)-3- (2-methoxybenzylamino)-2- phenylpiperidine
AU583543B2 (en) New adamantanamine derivatives, processes for their preparation and drugs in which they are present
IL75116A (en) Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same
IL88735A (en) N-benzimidazolyl 4-chloro-3- sulfamoylbenzoic acid hydrazides, a process for the preparation thereof and pharmaceutical compositions containing them
CA2009487A1 (en) Hydroxyalkane phosphonic acids and derivatives thereof and lubricants containing same
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
CA2308315A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
AU563426B2 (en) 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines
AU2240388A (en) Azachromane derivatives
GB2203751B (en) Bleach substitute for detergent compositions
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these

Legal Events

Date Code Title Description
RH Patent void